• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种由人类自然杀伤细胞和单核细胞表达的新型唾液酸结合免疫球蛋白样凝集素——siglec-7的鉴定与特性分析。

Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes.

作者信息

Nicoll G, Ni J, Liu D, Klenerman P, Munday J, Dubock S, Mattei M G, Crocker P R

机构信息

Medical Sciences Institute/Wellcome Trust Biocentre at Dundee Complex, Department of Biochemistry, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland.

出版信息

J Biol Chem. 1999 Nov 26;274(48):34089-95. doi: 10.1074/jbc.274.48.34089.

DOI:10.1074/jbc.274.48.34089
PMID:10567377
Abstract

We describe the characterization of sialic acid-binding Ig-like lectin-7 (siglec-7), a novel member of the siglec subgroup of the immunoglobulin superfamily. A full-length cDNA encoding siglec-7 was isolated from a human primary dendritic cell cDNA library. Siglec-7 is predicted to contain three extracellular immunoglobulin-like domains that comprise an N-terminal V-set domain and two C2-set domains, a transmembrane region and a cytoplasmic tail containing two tyrosine residues embodied in immunoreceptor tyrosine-based inhibition motif-like motifs. Overall, siglec-7 exhibited a high degree of sequence similarity to genes encoding CD33 (siglec-3), siglec-5, OBBP1/siglec-6, and OBBP-like protein and mapped to the same region on chromosome 19q13.3. When siglec-7 was expressed on COS or Chinese hamster ovary cells, it was able to mediate high levels of sialic acid-dependent binding to human erythrocytes and soluble sialoglycoconjugates, suggesting that it may be involved in cell-cell interactions. Among human peripheral blood leukocytes, siglec-7 was found to be present at low levels on granulocytes, intermediate levels on monocytes, and relatively high levels on a major subset of natural killer cells and a minor subset of CD8(+) T cells. Immunoprecipitation experiments indicated that siglec-7 is expressed as a monomer of approximately 65 kDa.

摘要

我们描述了唾液酸结合免疫球蛋白样凝集素-7(Siglec-7)的特征,它是免疫球蛋白超家族Siglec亚组的一个新成员。从人原代树突状细胞cDNA文库中分离出编码Siglec-7的全长cDNA。预测Siglec-7含有三个细胞外免疫球蛋白样结构域,包括一个N端V-set结构域和两个C2-set结构域、一个跨膜区以及一个含有两个酪氨酸残基的胞质尾,这些酪氨酸残基存在于基于免疫受体酪氨酸的抑制基序样基序中。总体而言,Siglec-7与编码CD33(Siglec-3)、Siglec-5、OBBP1/Siglec-6和OBBP样蛋白的基因表现出高度的序列相似性,并定位于19q13.3染色体上的同一区域。当Siglec-7在COS或中国仓鼠卵巢细胞上表达时,它能够介导高水平的唾液酸依赖性与人红细胞和可溶性唾液糖缀合物的结合,表明它可能参与细胞间相互作用。在人外周血白细胞中,发现Siglec-7在粒细胞上低水平存在,在单核细胞上中等水平存在,在自然杀伤细胞的一个主要亚群和CD8(+) T细胞的一个次要亚群上相对高水平存在。免疫沉淀实验表明,Siglec-7以约65 kDa的单体形式表达。

相似文献

1
Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes.一种由人类自然杀伤细胞和单核细胞表达的新型唾液酸结合免疫球蛋白样凝集素——siglec-7的鉴定与特性分析。
J Biol Chem. 1999 Nov 26;274(48):34089-95. doi: 10.1074/jbc.274.48.34089.
2
Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.从人树突状细胞中克隆并鉴定Siglec-10,一种免疫球蛋白超家族新的唾液酸结合成员。
J Biol Chem. 2001 Jul 27;276(30):28106-12. doi: 10.1074/jbc.M100467200. Epub 2001 May 17.
3
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily.唾液酸结合免疫球蛋白样凝集素8.免疫球蛋白超家族中一种新的嗜酸性粒细胞特异性成员。
J Biol Chem. 2000 Jan 14;275(2):861-6. doi: 10.1074/jbc.275.2.861.
4
Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily.唾液酸结合免疫球蛋白样凝集素7:免疫球蛋白超家族的一种唾液酸结合凝集素。
Glycobiology. 2000 Apr;10(4):431-8. doi: 10.1093/glycob/10.4.431.
5
Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33.唾液酸结合免疫球蛋白样凝集素-5的特性研究,一种在与CD33相关的髓样细胞上表达的新型糖蛋白。
Blood. 1998 Sep 15;92(6):2123-32.
6
Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.Siglecs的Siglec-3样亚组一个新的假定成员的两个剪接变体的克隆与分子特征分析
Biochem Biophys Res Commun. 2001 Jun 22;284(4):887-99. doi: 10.1006/bbrc.2001.5052.
7
Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.唾液酸结合免疫球蛋白样凝集素9(siglec-9)的克隆、特性分析及系统发育分析,siglec-9是CD33相关唾液酸结合免疫球蛋白样凝集素家族的新成员。与唾液酸合成途径共同进化的证据。
J Biol Chem. 2000 Jul 21;275(29):22127-35. doi: 10.1074/jbc.M002775200.
8
Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes.Siglec-9,一种免疫球蛋白超家族的新型唾液酸结合成员,广泛表达于人类血液白细胞上。
J Biol Chem. 2000 Jul 21;275(29):22121-6. doi: 10.1074/jbc.M002788200.
9
mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.mSiglec-E,一种新型的小鼠CD33相关唾液酸结合免疫球蛋白样凝集素(siglec),可募集含Src同源2(SH2)结构域的蛋白酪氨酸磷酸酶SHP-1和SHP-2。
Biochem J. 2001 Feb 1;353(Pt 3):483-92. doi: 10.1042/0264-6021:3530483.
10
Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes.19号染色体q13.4上唾液酸结合免疫球蛋白样凝集素(Siglec)基因座的基因组组织及两个新的Siglec假基因的克隆。
Gene. 2002 Mar 20;286(2):259-70. doi: 10.1016/s0378-1119(02)00432-8.

引用本文的文献

1
Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients.Siglec-7表达升高与乳腺癌患者不良的临床病理、免疫及治疗反应特征相关。
Front Immunol. 2025 Jun 6;16:1573365. doi: 10.3389/fimmu.2025.1573365. eCollection 2025.
2
Potentiating T cell tumor targeting using a combination of TCR with a Siglec-7 based CSR.使用T细胞受体与基于Siglec-7的化学诱导稳定化相结合的方法增强T细胞对肿瘤的靶向作用。
Front Immunol. 2025 May 13;16:1536868. doi: 10.3389/fimmu.2025.1536868. eCollection 2025.
3
Natural killer cell-based immunotherapy for cancer.
基于自然杀伤细胞的癌症免疫疗法。
J Immunol. 2025 Apr 17. doi: 10.1093/jimmun/vkaf036.
4
Differential Expression of Immune Checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on Circulating Natural Killer Cells - Insights from Healthy Donors Compared to Gastric Cancer Patients.循环自然杀伤细胞上免疫检查点TIM-3、LAG-3、TIGIT和Siglec-7的差异表达——来自健康供体与胃癌患者对比的见解
Oncol Res Treat. 2025 Apr 3:1-16. doi: 10.1159/000545429.
5
Soluble CD52 mediates immune suppression by human seminal fluid.可溶性CD52通过人类精液介导免疫抑制。
Front Immunol. 2024 Dec 16;15:1497889. doi: 10.3389/fimmu.2024.1497889. eCollection 2024.
6
Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer.唾液酸化糖蛋白通过与前列腺癌中的Siglec-7和Siglec-9结合来抑制免疫细胞杀伤。
J Clin Invest. 2024 Oct 22;134(24):e180282. doi: 10.1172/JCI180282.
7
Siglec-7 and Siglec-9 expression in primary triple negative and oestrogen receptor positive breast cancer and signalling.Siglec-7和Siglec-9在原发性三阴性和雌激素受体阳性乳腺癌中的表达及信号传导
Clin Transl Immunology. 2024 Sep 6;13(9):e1524. doi: 10.1002/cti2.1524. eCollection 2024 Sep.
8
subsp. RadD binds Siglec-7 and inhibits NK cell-mediated cancer cell killing.亚种RadD与唾液酸结合免疫球蛋白样凝集素7(Siglec-7)结合并抑制自然杀伤(NK)细胞介导的癌细胞杀伤作用。
iScience. 2024 May 31;27(6):110157. doi: 10.1016/j.isci.2024.110157. eCollection 2024 Jun 21.
9
The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy.Siglecs和唾液酸作为肿瘤免疫治疗生物标志物和治疗靶点的潜力
Cancers (Basel). 2024 Jan 10;16(2):289. doi: 10.3390/cancers16020289.
10
Multi-dimensional role of gangliosides in modulating cancer hallmarks and their prospects in targeted cancer therapy.神经节苷脂在调节癌症特征中的多维作用及其在靶向癌症治疗中的前景。
Front Pharmacol. 2023 Nov 27;14:1282572. doi: 10.3389/fphar.2023.1282572. eCollection 2023.